Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 87, Issue 22, Pages 12489-12495
Publisher
American Society for Microbiology
Online
2013-09-12
DOI
10.1128/jvi.01845-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
- (2013) F. Zielecki et al. JOURNAL OF VIROLOGY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Paramyxovirus V Proteins Disrupt the Fold of the RNA Sensor MDA5 to Inhibit Antiviral Signaling
- (2013) C. Motz et al. SCIENCE
- Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
- (2013) E. Kindler et al. mBio
- Herpes Simplex Virus 1 Tegument Protein US11 Downmodulates the RLR Signaling Pathway via Direct Interaction with RIG-I and MDA-5
- (2012) J. Xing et al. JOURNAL OF VIROLOGY
- Paramyxovirus V Proteins Interact with the RNA Helicase LGP2 To Inhibit RIG-I-Dependent Interferon Induction
- (2012) K. Childs et al. JOURNAL OF VIROLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
- (2012) M. A. Muller et al. mBio
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
- (2012) S. van Boheemen et al. mBio
- SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
- (2012) Allison L Totura et al. Current Opinion in Virology
- RIG-I-like receptors: cytoplasmic sensors for non-self RNA
- (2011) Hiroki Kato et al. IMMUNOLOGICAL REVIEWS
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
- (2011) Roland Züst et al. NATURE IMMUNOLOGY
- Type I Interferon Reaction to Viral Infection in Interferon-Competent, Immortalized Cell Lines from the African Fruit Bat Eidolon helvum
- (2011) Susanne E. Biesold et al. PLoS One
- Murine Coronavirus Induces Type I Interferon in Oligodendrocytes through Recognition by RIG-I and MDA5
- (2010) J. Li et al. JOURNAL OF VIROLOGY
- Species-independent bioassay for sensitive quantification of antiviral type I interferons
- (2010) Thomas Kuri et al. Virology Journal
- Human Coronavirus NL63 Open Reading Frame 3 encodes a virion-incorporated N-glycosylated membrane protein
- (2010) Marcel A Müller et al. Virology Journal
- SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism
- (2010) Xiaolu Lu et al. VIRUS GENES
- NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
- (2009) M. Habjan et al. JOURNAL OF VIROLOGY
- Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression
- (2009) C. R. Kimberlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia
- (2008) J. K. Roth-Cross et al. JOURNAL OF VIROLOGY
- SARS coronavirus accessory proteins
- (2007) Krishna Narayanan et al. VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started